GENTRACK GROUP LIMITED (GTK)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

GTK - GENTRACK GROUP LIMITED

FNArena Sector : Software & Services
Year End: September
GICS Industry Group : Software & Services
Debt/EBITDA: 0.56
Index: ASX300 | ALL-ORDS | ALL-TECH

LAST PRICE CHANGE +/- CHANGE % VOLUME

$11.56

20 Dec
2024

0.000

OPEN

$11.04

0.000

HIGH

$11.64

168,727

LOW

$11.04

TARGET
$13.067 13.0% upside
Franking for last dividend paid out: 9%
OTHER COMPANIES IN THE SAME SECTOR
360 . ADA . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . KYP . NET . NXL . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
GTK: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) 16.2 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 71.2 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/12 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx8.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx196.6 M
Book Value Per Share xxxxxxxxxxxxxxx184.2
Net Operating Cash Flow xxxxxxxxxxxxxxx32.4 M
Net Profit Margin xxxxxxxxxxxxxxx4.48 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.90 %
Return on Invested Capital xxxxxxxxxxxxxxx4.55 %
Return on Assets xxxxxxxxxxxxxxx3.55 %
Return on Equity xxxxxxxxxxxxxxx4.90 %
Return on Total Capital xxxxxxxxxxxxxxx10.01 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx31.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx13 M
Total Debt xxxxxxxxxxxxxxx16 M
Goodwill - Gross xxxxxxxxxxxxxxx103 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx61 M
Price To Book Value xxxxxxxxxxxxxxx5.35

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.0 M
Capex % of Sales xxxxxxxxxxxxxxx0.51 %
Cost of Goods Sold xxxxxxxxxxxxxxx147 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx30 M
Research & Development xxxxxxxxxxxxxxx21 M
Investments - Total xxxxxxxxxxxxxxx11 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

27/11/2024

1

Buy, High Risk

$11.80

2.08%

Gentrack Group's FY24 revenue and underlying earnings (EBITDA) exceeded Shaw and Partners' forecasts by 7% and 12%, respectively. Underlying cash earnings margins expanded by 2.2 percentage points, demonstrating clear operating leverage, note the analysts.

The broker believes FY25 consensus estimates are achievable, and FY26 earnings (EBITDA) margins could reach the upper end of the 15-20% range, supporting a more optimistic market view of long-term margin potential.

Shaw and Partners raises the target price to $11.80 from $10.10, driven by higher medium-term cash flow forecasts and a lower assumed weighted average cost of capital (WACC). The Buy, High Risk rating is maintained.

FORECAST
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 16.79 cents.
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 26.88 cents.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxx xxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

28/11/2024

4

Underweight

-

-

Following FY24 results for Gentrack Group, Jarden notes ongoing momentum with the 50% underlying revenue increase supported by a 102% lift in non-recurring revenues (NRR) and a 31% rise for annual recurring revenue (ARR).

The performance of Utilities was a highlight, in the broker's opinion, due to the g2 platform upgrade at New Zealand-listed Genesis Energy and project work across the UK customer base on the back of regulatory change.

While management reiterated medium-term targets, the analyst suggest the lack of FY25 guidance creates some uncertainty.

The target rises to NZ$7.65 from $7.00. The Underweight rating is maintained.

FORECAST
Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 18.72 cents.
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 28.26 cents.

Goldman Sachs

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Extra Coverage Research History >

GTK STOCK CHART

FNArena News on GTK

1
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
2
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
3
FNArena Corporate Results Monitor – 09-12-2024

Dec 09 2024 - Australia
4
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View
5
November In Review: Valuation Concern Trumped

Dec 04 2024 - Australia

Latest Software & Services News

1
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
2
Higher Margins Underpin Gentrack’s Ambitions

Nov 28 2024 - Small Caps
3
Targets Jump For Embattled WiseTech

Nov 28 2024 - Australia
4
Nuix Rises From The Ashes

Nov 08 2024 - Small Caps
5
WiseTech In Global Supply Chain Sweet Spot

Oct 10 2024 - Australia
6
Quality By Any Objective Measure

Oct 04 2024 - Small Caps
7
Gen.Ai: Infrastructure Arms Race Powers Ahead

Sep 16 2024 - International
8
Gentrack Shares Breaking Out

Sep 10 2024 - Technicals
9
NextDC: Building A Generative AI Future 

Sep 09 2024 - Australia
10
In Brief: More US Millionaires & More From ECB

Jul 19 2024 - Weekly Reports